Companies/US/GANX

GAIN THERAPEUTICS, INC.

Last · NasdaqGM$1.57-0.07 (-4.27%)stale · yahoo · 59h ago
Vol 319.4K ≈ 501.5K
Market cap$68.52M43.6M sh
P/E · TTM-3.2fwd -2.3 · eps -0.50 · loss
Beta0.19vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.53$4.34
Volume319.4Ksession

Issuer

Legal nameGAIN THERAPEUTICS, INC.
HQUnited States (US)
ListingUS GANX
ISINUS36269B1052
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001819411
CIK0001819411
Websitegaintherapeutics.com
LinkedIn
Employees21
AddressGain Therapeutics, Inc. 4800 Montgomery Lane 20814, Bethesda
Loading chart…

Press & signals

2 recent
  • GlobeNewswire

    Gain Therapeutics Reports Financial Results for Second Quarter 2026 and Provides Corporate Update

  • GlobeNewswire

    Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

Documents

FormReporting forFiledFlags
8-KCurrent Report (8-K)
—2026-10-010
8-KCurrent Report (8-K)
—2026-09-280
10-Q
2026-06-302026-08-11 3
8-K8-K: Other Events
2026-06-292026-06-290
8-K8-K: Submission of Matters to a Vote of Security Holders
2026-06-242026-06-250
Showing 5 of 14 filings